CUC Future Growth
Future criteria checks 3/6
CUC is forecast to grow earnings and revenue by 12.4% and 19.2% per annum respectively. EPS is expected to grow by 10.3% per annum. Return on equity is forecast to be 9.3% in 3 years.
Key information
12.4%
Earnings growth rate
10.3%
EPS growth rate
Healthcare earnings growth | 8.5% |
Revenue growth rate | 19.2% |
Future return on equity | 9.3% |
Analyst coverage | Low |
Last updated | 25 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 61,203 | 3,563 | N/A | 6,036 | 2 |
3/31/2026 | 49,979 | 3,343 | -1,429 | 5,366 | 4 |
3/31/2025 | 43,133 | 2,363 | -1,026 | 4,153 | 3 |
3/31/2024 | 33,025 | 2,595 | -747 | 4,156 | N/A |
12/31/2023 | 31,133 | 1,779 | N/A | N/A | N/A |
9/30/2023 | 31,862 | 1,952 | N/A | N/A | N/A |
6/30/2023 | 32,737 | 1,992 | N/A | N/A | N/A |
3/31/2023 | 35,210 | 2,423 | N/A | N/A | N/A |
3/31/2022 | 35,314 | 2,707 | N/A | N/A | N/A |
3/31/2021 | 16,606 | 1,100 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9158's forecast earnings growth (12.4% per year) is above the savings rate (0.2%).
Earnings vs Market: 9158's earnings (12.4% per year) are forecast to grow faster than the JP market (9.4% per year).
High Growth Earnings: 9158's earnings are forecast to grow, but not significantly.
Revenue vs Market: 9158's revenue (19.2% per year) is forecast to grow faster than the JP market (4.4% per year).
High Growth Revenue: 9158's revenue (19.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9158's Return on Equity is forecast to be low in 3 years time (9.3%).